Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karim Taha

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|December 11, 2025
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific regionHo Jin Kim, Suzanne J Hodgkinson, Long-Sun Ro, et al.
Heart Rhythm|May 31, 2021
Echocardiographic deformation imaging unmasks global and regional mechanical dysfunction in patients with idiopathic ventricular fibrillation: A multicenter case-control studySanne A Groeneveld, Martijn H van der Ree, Karim Taha, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Open Heart|May 4, 2025
Incident HFpEF and time-dependent changes in markers of LVDD severity in women and men with preclinical LVDDAnne Margje Lisa Naomi van Ommen, Elisa Dal Canto, Ernest Diez Benavente, et al.
JACC. Cardiovascular Imaging|November 22, 2020
Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of SymptomsKarim Taha, Wouter P Te Rijdt, Tom E Verstraelen, et al.
The International Journal of Cardiovascular Imaging|August 11, 2023
Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriersKarim Taha, Rutger R van de Leur, Melle Vessies, et al.
European Heart Journal. Cardiovascular Imaging|September 13, 2021
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriersKarim Taha, Tom E Verstraelen, Remco de Brouwer, et al.
European Heart Journal. Cardiovascular Imaging|July 20, 2023
The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathyFeddo P Kirkels, Christine Rootwelt-Norberg, Laurens P Bosman, et al.
Cardiovascular Research|June 11, 2020
Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillationFunsho E Fakuade, Vanessa Steckmeister, Fitzwilliam Seibertz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|December 11, 2025
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific regionHo Jin Kim, Suzanne J Hodgkinson, Long-Sun Ro, et al.
Heart Rhythm|May 31, 2021
Echocardiographic deformation imaging unmasks global and regional mechanical dysfunction in patients with idiopathic ventricular fibrillation: A multicenter case-control studySanne A Groeneveld, Martijn H van der Ree, Karim Taha, et al.
Multiple Sclerosis International|January 13, 2017
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus RisksRaed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al.
Open Heart|May 4, 2025
Incident HFpEF and time-dependent changes in markers of LVDD severity in women and men with preclinical LVDDAnne Margje Lisa Naomi van Ommen, Elisa Dal Canto, Ernest Diez Benavente, et al.
JACC. Cardiovascular Imaging|November 22, 2020
Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of SymptomsKarim Taha, Wouter P Te Rijdt, Tom E Verstraelen, et al.
The International Journal of Cardiovascular Imaging|August 11, 2023
Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriersKarim Taha, Rutger R van de Leur, Melle Vessies, et al.
European Heart Journal. Cardiovascular Imaging|September 13, 2021
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriersKarim Taha, Tom E Verstraelen, Remco de Brouwer, et al.
European Heart Journal. Cardiovascular Imaging|July 20, 2023
The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathyFeddo P Kirkels, Christine Rootwelt-Norberg, Laurens P Bosman, et al.
Cardiovascular Research|June 11, 2020
Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillationFunsho E Fakuade, Vanessa Steckmeister, Fitzwilliam Seibertz, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
Pageof 4